IREDEX Ophthalmology Revenues Up to $9.2M in 4Q

IREDEX, laser-based medical systems developer and manufacturer, has announced that its ophthalmology revenues in the fourth quarter of 2012 were $9.2 million, up from $8.6 million in the fourth quarter of 2011, a nearly 7 percent increase, according to a Daily Markets report.

Advertisement

Ophthalmology revenues in the fourth quarter of 2012 were a record high for the Mountain View, Calif.-based IREDEX.

More Articles on Ophthalmology:
NY Vision Group Opens Tribeca Location
Transcend Medical Joins COMPASS Clinical Study to Assess CyPass Micro-Stent
Ocular Therapeutix Seeking FDA Approval for ReSure Sealant

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.